Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $504.2700 (2.2%) ($488.8900 - $511.0100) on Mon. Apr. 6, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.68% (three month average) | RSI | 52 | Latest Price | $504.2700(2.2%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.2% a day on average for past five trading days. | Weekly Trend | REGN advances 2.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(55%) XLV(45%) IVW(37%) IWF(36%) QQQ(36%) | Factors Impacting REGN price | REGN will decline at least -1.84% in a week (0% probabilities). VIXM(-19%) VXX(-8%) UUP(-5%) TBT(-5%) IYT(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.84% (StdDev 3.68%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $496.29(1.61%) | 10 Day Moving Average | $474.88(6.19%) | 20 Day Moving Average | $469.71(7.36%) | To recent high | 0% | To recent low | 50% | Market Cap | $53.467b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |